Cutler Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-3,000
Closed -$6K – 2749
2023
Q4
$6K Buy
+3,000
New +$110K ﹤0.01% 2646
2022
Q2
– Sell
-9,200
Closed -$1K – 5218
2022
Q1
$1K Sell
9,200
-800
-8% -$49K ﹤0.01% 4962
2021
Q4
$78K Sell
10,000
-22,500
-69% -$1.17M ﹤0.01% 2039
2021
Q3
$787K Sell
32,500
-7,500
-19% -$445K 0.04% 569
2021
Q2
$556K Buy
40,000
+3,500
+10% +$267K 0.03% 709
2021
Q1
$427K Buy
36,500
+29,000
+387% +$2.67M 0.02% 815
2020
Q4
$70K Buy
+7,500
New +$917K ﹤0.01% 1765
2020
Q3
– Sell
-600
Closed -$17K – 4874
2020
Q2
$17K Buy
+600
New +$124K ﹤0.01% 2500
2019
Q4
– Sell
-3,800
Closed -$9K – 4194
2019
Q3
$9K Buy
3,800
+1,400
+58% +$229K ﹤0.01% 2677
2019
Q2
$9K Buy
+2,400
New +$285K ﹤0.01% 2746
2018
Q4
– Sell
-1,500
Closed -$5K – 4165
2018
Q3
$5K Buy
1,500
+200
+15% +$21.1K ﹤0.01% 3037
2018
Q2
$21K Sell
1,300
-900
-41% -$87.3K ﹤0.01% 2159
2018
Q1
$26K Buy
2,200
+1,300
+144% +$140K ﹤0.01% 2092
2017
Q4
$10K Sell
900
-2,400
-73% -$227K ﹤0.01% 3124
2017
Q3
$1K Sell
3,300
-1,100
-25% -$96.1K ﹤0.01% 5418
2017
Q2
$24K Buy
4,400
+1,200
+38% +$101K ﹤0.01% 3226
2017
Q1
$9K Buy
+3,200
New +$230K ﹤0.01% 4142

Other funds holding LKFT

Cutler Group's LKFT Position: Q1 2024 in Review

Cutler Group sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2024, closing a stake of 345 shares — an estimated $12.8K sold.

Cutler Group first reported a position in LKFT in Q4 2016 and held it in 21 quarters. The position peaked at $1.81M in Q2 2021. 82 funds tracked by Wall St. Rank hold LKFT as of Q1 2024.

  • Cutler Group reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 345 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2024, an estimated $12.8K.
  • Cutler Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2016 and held it in 21 quarters.
  • Cutler Group's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.81M in Q2 2021.
  • 82 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.